Medtronic (MDT) Reports Clinical Study to Evaluate the CoreValve Evolut PRO System

September 21, 2017 9:33 AM EDT Send to a Friend
Medtronic plc (NYSE: MDT) today announced a new post-market clinical study to evaluate its CoreValve(TM) Evolut(TM) PRO valve in everyday ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login